18 participants
Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-10
- Start Date:
- 2026-08-01
- Completion:
- 2029-05-30
Conditions
- Relapsed or Refractory Acute Leukemia
- Relapsed or Refractory Acute Lymphoblastic Leukemia
- Relapsed or Refractory Acute Myeloid Leukemia (AML)
Interventions
- BIOLOGICAL
No Results Yet